Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.54% |
| 2 | Technology | 10.66% |
| 3 | Financials | 10.63% |
| 4 | Consumer Discretionary | 9.38% |
| 5 | Industrials | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
PUT
S&P Global
SPGI
$126B
| $7.37M | 0.01% |
+35,000
| New | +$6.78M |
|
|
K
1477
DELISTED
Kellanova
K
| $7.37M | 0.01% |
136,732
-131,375
| -49% | -$7.01M |
|
|
RST
1478
DELISTED
ROSETTA STONE INC
RST
| $7.35M | 0.01% |
336,480
+111,717
| +50% | +$1.95M |
|
1479
Universal Display
OLED
$3.85B
| $7.33M | 0.01% |
+47,973
| New | +$5.94M |
|
|
AGN
1480
CALL
DELISTED
Allergan plc
AGN
| $7.32M | 0.01% |
+50,000
| New | +$7.25M |
|
|
BEST
1481
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $7.32M | 0.01% |
69,929
+65,297
| +1,410% | +$6.81M |
|
1482
Terex
TEX
$7.84B
| $7.31M | 0.01% |
+227,575
| New | +$7.22M |
|
1483
Corcept Therapeutics
CORT
$10.1B
| $7.3M | 0.01% |
622,273
-46,564
| -7% | -$579K |
|
1484
CALL
LivaNova
LIVN
$4.51B
| $7.29M | 0.01% |
+75,000
| New | +$7M |
|
1485
Apple Hospitality REIT
APLE
$3.97B
| $7.29M | 0.01% |
446,968
-355,162
| -44% | -$5.69M |
|
|
JAG
1486
DELISTED
Jagged Peak Energy Inc.
JAG
| $7.26M | 0.01% |
693,786
+646,504
| +1,367% | +$6.68M |
|
1487
PUT
Charles River Laboratories
CRL
$11.6B
| $7.26M | 0.01% |
50,000
+45,000
| +900% | +$5.91M |
|
|
MFA
1488
MFA Financial
MFA
$935M
| $7.25M | 0.01% |
249,375
+103,721
| +71% | +$3M |
|
1489
Minerva Neurosciences
NERV
$199M
| $7.25M | 0.01% |
115,316
-41,144
| -26% | -$2.47M |
|
|
IPHI
1490
DELISTED
INPHI CORPORATION
IPHI
| $7.25M | 0.01% |
165,685
+143,011
| +631% | +$5.69M |
|
|
ADMS
1491
DELISTED
Adamas Pharmaceuticals
ADMS
| $7.24M | 0.01% |
1,017,983
+538,084
| +112% | +$4.84M |
|
1492
AeroVironment
AVAV
$7.91B
| $7.24M | 0.01% |
105,795
+81,436
| +334% | +$6.14M |
|
1493
CALL
Cigna
CI
$79.6B
| $7.24M | 0.01% |
+45,000
| New | +$8.22M |
|
|
SFIX
1494
Stitch Fix
SFIX
$563M
| $7.2M | 0.01% |
255,016
+123,421
| +94% | +$3.07M |
|
1495
Parker-Hannifin
PH
$125B
| $7.18M | 0.01% |
41,857
-25,133
| -38% | -$4.17M |
|
1496
PUT
ExxonMobil
XOM
$634B
| $7.17M | 0.01% |
+88,800
| New | +$6.77M |
|
1497
Performance Food Group
PFGC
$18.1B
| $7.17M | 0.01% |
180,883
-529,664
| -75% | -$19.4M |
|
1498
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46B
| $7.14M | 0.01% |
27,550
-23,923
| -46% | -$6.02M |
|
|
CMTA
1499
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| $7.13M | 0.01% |
273,286
+248,426
| +999% | +$4.64M |
|
1500
ASML
ASML
$608B
| $7.12M | 0.01% |
37,856
-2,794
| -7% | -$495K |
|
Similar funds
Millennium Management's Q1 2019 Portfolio in Review
As of Q1 2019, Millennium Management held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Millennium Management withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, Millennium Management opened a new position in Zimmer Biomet worth $232M.
- Millennium Management's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Millennium Management added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Millennium Management's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Millennium Management fully exited Merck in Q1 2019, selling an estimated $375M.
- Millennium Management's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Millennium Management opened 914 new positions and closed 675 in Q1 2019.
- Millennium Management's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.